RhumbLine Advisers’s Juno Therapeutics, Inc. JUNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-61,919
| Closed | -$2.83M | – | 2836 |
|
|
2017
Q4 | $2.83M | Buy |
61,919
+1,493
| +2% | +$68.2K | 0.01% | 1422 |
|
|
2017
Q3 | $2.71M | Buy |
60,426
+784
| +1% | +$35.2K | 0.01% | 1409 |
|
|
2017
Q2 | $1.78M | Sell |
59,642
-9,844
| -14% | -$294K | ﹤0.01% | 1656 |
|
|
2017
Q1 | $1.54M | Buy |
69,486
+3,853
| +6% | +$85.5K | ﹤0.01% | 1697 |
|
|
2016
Q4 | $1.24M | Buy |
65,633
+5,820
| +10% | +$110K | ﹤0.01% | 1737 |
|
|
2016
Q3 | $1.8M | Buy |
59,813
+4,462
| +8% | +$134K | ﹤0.01% | 1481 |
|
|
2016
Q2 | $2.13M | Buy |
55,351
+44,647
| +417% | +$1.72M | 0.01% | 1296 |
|
|
2016
Q1 | $408K | Sell |
10,704
-250
| -2% | -$9.53K | ﹤0.01% | 2356 |
|
|
2015
Q4 | $482K | Buy |
10,954
+570
| +5% | +$25.1K | ﹤0.01% | 2258 |
|
|
2015
Q3 | $423K | Buy |
10,384
+637
| +7% | +$25.9K | ﹤0.01% | 2338 |
|
|
2015
Q2 | $520K | Buy |
+9,747
| New | +$520K | ﹤0.01% | 2303 |
|